Jesus M. Lopez-Marti

IISFJD Research Health Institute of Fundacion Jimenez Diaz

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Figure S4 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

David S. Moura,Jesus M. Lopez-Marti,Iva Benesova,Carlos de Andrea,Davide di Lernia,Serena Lacerenza,Jose L. Mondaza-Hernandez,Marta Martin-Ruiz,Marta Ramirez-Calvo,Giovanni Grignani,Javier Martinez-Trufero,Andres Redondo,Claudia Valverde,Silvia Stacchiotti,Antonio Lopez-Pousa,José A. Lopez-Guerrero,Antonio Gutierrez,Victor Encinas-Tobajas,Nadia Hindi,Dario Sangiolo,Jose A. Lopez-Martin,Zuzana Ozaniak Strizova,Javier Martin-Broto

crossref（2024）

引用0浏览0引用

Supplementary Table S4 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

crossref（2024）

引用0浏览0引用

Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

David S. Moura,Jesus M. Lopez-Marti,Iva Benesova,Carlos de Andrea,Davide di Lernia,Serena Lacerenza,Jose L. Mondaza-Hernandez,Marta Martin-Ruiz,Marta Ramirez-Calvo,Giovanni Grignani,Javier Martinez-Trufero,Andres Redondo,Claudia Valverde,Silvia Stacchiotti,Antonio Lopez-Pousa,Jose A. Lopez-Guerrero,Antonio Gutierrez,Victor Encinas-Tobajas,Nadia Hindi,Dario Sangiolo,Jose A. Lopez-Martin,Zuzana Ozaniak Strizova,Javier Martin-Broto

CLINICAL CANCER RESEARCHno. 22 (2024): 5192-5206

引用0浏览0WOS引用

Supplementary Figure S1 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

crossref（2024）

引用0浏览0引用

Supplementary Table S2 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

crossref（2024）

引用0浏览0引用

Supplementary Table S1 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

crossref（2024）

引用0浏览0引用

Supplementary Figure S2 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

crossref（2024）

引用0浏览0引用

Supplementary Table S3 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

crossref（2024）

引用0浏览0引用

Supplementary Figure S3 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

crossref（2024）

引用0浏览0引用

Supplementary Figure S5 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

crossref（2024）

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn